⚠ COVID-19 INFORMATION: Resources, Vaccine Information

Publications

Filter by:

Publications

A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children's Oncology Group study

Armstrong, A. E.; Gadd, S.; Huff, V.; Gerhard, D. S.; Dome, J. S.; Perlman, E. J. PLoS One. 2018 Dec 14; 13(12):e0208936

Impact of cyclophosphamide and etoposide on outcome of clear cell sarcoma of the kidney treated on the National Wilms Tumor Study-5 (NWTS-5)

Seibel, N. L.; Chi, Y. Y.; Perlman, E. J.; Tian, J.; Sun, J.; Anderson, J. R.; Ritchey, M. L.; Thomas, P. R.; Miser, J.; Kalapurakal, J. A.; Grundy, P. E.; Green, D. M. Pediatr Blood Cancer. 2018 Sep 27; 66(1):e27450

The classification of pediatric and young adult renal cell carcinomas registered on the Children's Oncology Group (COG) protocol AREN03B2 after focused genetic testing

Cajaiba, M. M.; Dyer, L. M.; Geller, J. I.; Jennings, L. J.; George, D.; Kirschmann, D.; Rohan, S. M.; Cost, N. G.; Khanna, G.; Mullen, E. A.; Dome, J. S.; Fernandez, C. V.; Perlman, E. J. Cancer. 2018 Jun 16

Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study

Dix, D. B.; Seibel, N. L.; Chi, Y. Y.; Khanna, G.; Gratias, E.; Anderson, J. R.; Mullen, E. A.; Geller, J. I.; Kalapurakal, J. A.; Paulino, A. C.; Perlman, E. J.; Ehrlich, P. F.; Malogolowkin, M.; Gastier-Foster, J. M.; Wagner, E.; Grundy, P. E.; Fernandez, C. V.; Dome, J. S. J Clin Oncol. 2018 Apr 17; 36(16):1564-1570

Reply to B. Zhang et al

Fernandez, C. V.; Perlman, E. J.; Gastier-Foster, J.; Geller, J. I.; Mullen, E. A.; Ehrlich, P. F.; Dome, J. S. J Clin Oncol. 2018 Apr 4; 36(14):1454-1455